Related Experiment Video
Updated: Jun 29, 2025

08:17
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
Published on: June 7, 2015
15.7K
Novel frameless LINAC radiosurgery solution for uveal melanoma
Louis Cappelli1, Mehak Khan2, Sudheshna Vemula2
1Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, PA, United States.
Frontiers in Oncology
|April 9, 2024
Summary
A new non-invasive, frameless LINAC-based system for fractionated stereotactic radiosurgery (fSRS) offers precise treatment for uveal melanoma. This organ-preservation method demonstrates high setup accuracy and tolerability in initial patient trials.
Area of Science:
- Ophthalmology
- Radiation Oncology
- Medical Imaging
Background:
- Uveal melanoma (UM) treatment has shifted towards organ-preservation, with radiation therapy replacing enucleation.
- Fractionated stereotactic radiosurgery (fSRS) is a key organ-preservation technique for UM.
- Novel, non-invasive delivery methods are needed to improve fSRS for ocular tumors.
Purpose of the Study:
- To develop and evaluate a novel non-invasive, frameless LINAC-based solution for fSRS treatment of uveal melanoma.
- To assess the feasibility, tolerability, and setup accuracy of the developed system.
Main Methods:
- A stereotactic ocular localization box was designed and 3D-printed, featuring adjustable LED lights and a CCD camera for eye position monitoring.
- The system incorporates infrared spheres compatible with the ExacTRAC image-guided radiation therapy (IGRT) system.
- Treatment plans involved conformal dynamic arcs with a 6MV flattening filter-free photon beam, delivering 50Gy in 5 fractions, with real-time eye movement tracking.
Main Results:
- The stereotactic ocular localization box demonstrated high setup accuracy, with residual setup errors in lateral, longitudinal, and vertical directions below 0.3 mm.
- Rotational errors were also minimal, with pitch, roll, and couch rotation errors below 0.3 degrees.
- All 10 treated patients successfully completed the fSRS treatment, indicating feasibility and tolerability.
Conclusions:
- A novel non-invasive, frameless LINAC-based solution for fSRS of uveal melanoma and other ocular tumors has been successfully developed.
- The system is well-tolerated and achieves high setup accuracy, offering a promising organ-preservation approach.
- Future multi-center trials are warranted to assess the efficacy and reproducibility of this innovative therapeutic solution.

